Nasdaq

ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg, First Needle-Free Epinephrine Treatment for Children Ages 4 and Up

neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 mg, ...
Yahoo

FDA approves first non-needle treatment for severe allergic reactions

Add Yahoo as a preferred source to see more of our stories on Google. On August 9 the U.S. Food and Drug Administration (FDA) announced it had approved an epinephrine spray for emergency treatment of ...
The Washington Post

FDA approves needle-free alternative to EpiPen for allergic reactions

A newly approved nasal spray for serious allergic reactions will serve as a critical alternative to EpiPens and other auto-injectors, helping to treat such reactions quicker in people who are afraid ...
Local 12 WKRC Cincinnati

No more needles? FDA approves first nasal spray to treat dangerous allergic reactions

(AP) - U.S. health officials on Friday approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen. The Food and Drug Administration said it ...
FOX8 Cleveland

FDA approves first needle-free alternative to treat dangerous allergic reactions

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (AP) – U.S. health officials on Friday ...